In the ever-evolving world of skincare, salicylic acid stands out as a revolutionary ingredient for those battling persistent ...
The Food and Drug Administration (FDA) has expanded the approval of Jylamvo (methotrexate) to include the treatment of pediatric patients with acute lymphoblastic leukemia (ALL), as part of a ...
The efficacy and safety of risankizumab remains similar across racial and ethnic groups of patients with moderate to severe plaque psoriasis.
Phase 3b trial evaluating Tremfya (guselkumab) in low body surface area plaque psoriasis found the treatment improved clearance.
Jersey City-based Organon has completed its acquisition of Dermavant Sciences Ltd. from Roivant. Dermavant is a company ...
GlobalData on MSN15h
Dermavant acquisition expands Organon’s dermatology portfolioThe future of dermatology depends on innovative treatments like VTAMA, and Organon’s acquisition of Dermavant allows us to ...
The Cambridge, England-based pharmaceutical company focused on developing next-generation kinase inhibitors for autoimmune disease and cancer said pretax loss widened to GBP4.6 million in the ...
The anti-IL-23 monoclonal antibody, called picankibart, was shown to clear or nearly clear all lesions after 16 weeks among 48.2% of the 82 participating Chinese patients that were classified as ...
The FDA has expanded the approval for Jylamvo, an oral methotrexate solution, to include pediatric patients with acute ...
Novartis exceeded analyst expectations in the third quarter, driven primarily by the strong U.S. sales of Cosentyx, as well ...
Salicylic acid is a topical skincare ingredient used to treat conditions, like acne, warts, and psoriasis. Here, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback